Global Anaesthesia Drugs Market Set To Grow To $10.5bn By 2022
02 August 2018
Visiongain’ has launched a new pharma report Anaesthesia Drugs Market Report : Local Anaesthesia, General Anaesthesia, Inhalation Anaesthesia, Intravenous Anaesthesia, Topical Anaesthesia
This anaesthesia drugs market can be broadly segmented into type and routes of administration. The market is segregated further by type as local anaesthesia and general anaesthesia. Inhalation intravenous and topical are the main forms of routes of administration. The market has also been geographically segmented into North America (US, Canada), Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Asia-Pacific (India, China, Japan, Rest of Asia-Pacific), Rest of World (Brazil, Mexico, Russia, South Africa).
The lead analyst of the report commented “The global anaesthesia drugs market is projected to grow at lucrative rate during the forecast period owing to a rising number of surgical procedures globally, developing healthcare infrastructure in emerging economies, and growing number of geriatric population. The escalating prevalence of cancer, stroke, arthritis, and neurological diseases leads to a rising number of surgical procedures. In addition, rising number of road accidents and trauma cases will further drive the growth of the market.”
Leading companies featured in the report include Baxter International, Inc., AbbVie, PAION AG, Pfizer, Hameln Pharmaceuticals, AstraZeneca, Fresenius Kabi, Maruishi Pharmaceuticals, Pacira Pharmaceuticals, Inc
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100
About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Recent News
Visiongain Publishes Meningococcal Vaccines Market Report 2024-2034
The global Meningococcal Vaccines market is projected to grow at a CAGR of 2.5% by 2034
26 March 2024
Read
Visiongain Publishes Medical Imaging Devices Market Report 2024-2034
The global Medical Imaging Devices market was valued at US$ 54.3 billion in 2024 and is projected to grow at a CAGR of 4.6% during the forecast period 2024-2034.
20 March 2024
Read
Visiongain Publishes Women’s Health Market Report 2024-2034
The global Women’s Health market was estimated to be valued at US$ 61 billion in 2034 and is expected to register a CAGR of 4.6% from 2024 to 2034.
18 March 2024
Read
Visiongain Publishes Clinical Trial Supplies Market Report 2024-2034
The global Clinical Trial Supplies market is estimated at US$4,146.7 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period 2024-2034.